ADIL
ADIL
NASDAQ · Pharmaceuticals

Adial Pharmaceuticals Inc

$1.43
+0.01 (+0.70%)
As of May 9, 2:06 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +1,128.7% upside
Low Target $13.09
Average Target $17.57
High Target $22.70
Current Price $1.43
Current
$1.43
Target
$17.57
$13.09 $17.57 avg $22.70
Scenario Analysis
Bear Case
$13.09
815.4%
Low target
Base Case
$17.57
+1,128.7%
Avg target
Bull Case
$22.70
+1,487.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
Target vs 52W High
$17.57
-96.0% vs high
Next Earnings Report
May 12, 2026
1d
tomorrow
EPS Est: $-2.78
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%